به جمع مشترکان مگیران بپیوندید!

تنها با پرداخت 70 هزارتومان حق اشتراک سالانه به متن مقالات دسترسی داشته باشید و 100 مقاله را بدون هزینه دیگری دریافت کنید.

برای پرداخت حق اشتراک اگر عضو هستید وارد شوید در غیر این صورت حساب کاربری جدید ایجاد کنید

عضویت

جستجوی مقالات مرتبط با کلیدواژه « diphtheria » در نشریات گروه « پزشکی »

  • سمانه محمدجواد، مجتبی نوفلی*، علی نظری شیروان، پژواک خاکی
    پیش زمینه و هدف

    دیفتری یک بیماری حاد دستگاه تنفسی قابل کنترل با واکسن است که عامل آن باکتری گرم مثبت کورینه باکتریوم دیفتریه است. ازآنجایی که تهیه، تخلیص و سمیت زدایی واکسن این بیماری شامل مراحل متعدد و پیچیده ای است، بنابراین، تحقیق حاضر باهدف کوتاه کردن مراحل مختلف تخلیص توکسویید، انجام گرفت.

    مواد و روش ها

    برای این منظور و با روش مقایسه ای و مداخله ای، ابتدا بهینه سازی سه فاکتور مقدار آهن محیط کشت، دمای کشت و میزان دور شیکر برای تولید هر چه بیشتر توکسین انجام شد. در هر مورد آزمایش سه بار تکرار شد و مقادیر Lf و Kf جهت ارزیابی تولید توکسین تست شدند. پس از غیر فعال سازی توکسین و تولید توکسویید، جهت تصفیه و تخلیص توکسویید از تقلیل مرحله ای با کنترل فاکتورهای کیفی استفاده گردید. در این روش از مراحل اولترافیلتراسیون، ترسیب، دیالیز و کروماتوگرافی با ستون سفادکس G-25 استفاده شد. در شرایط تقلیل مرحله ای نیز در حالت اول مرحله دیالیز، در حالت دوم مرحله کروماتوگرافی و در حالت سوم هر دو مرحله دیالیز و کروماتوگرافی حذف شدند. نتایج هر روش با انجام SDS-PAGE و بررسی خلوص با نرم افزار Minitab 18 ارزیابی گردید ((p‹0.05.

    یافته ها

    نتایج حاصل برای بهینه سازی محیط کشت نشان داد که مقدار آهن با غلظت 1 میلی گرم در لیتر، دمای 35 درجه سانتی گراد و دور شیکر rpm 200 منجر به تولید بیشترین مقدار توکسین می شوند (p‹0.05). در آزمایش های مربوط به تقلیل مراحل تصفیه و تخلیص توکسویید، بهترین نتایج در سری نمونه های تخلیص شده با مراحل اولترافیلتراسیون، ترسیب و کروماتوگرافی ستونی به دست آمد.

    بحث و نتیجه گیری

    ازآنجاکه در تولید صنعتی، زمان و هزینه دو فاکتور کلیدی هستند، لذا با حذف مرحله دیالیز که به طور تقریبی دو هفته به طول می انجامد، می توان تولید توکسویید برای واکسن دیفتری را با هزینه کمتر و در زمان کوتاه تر انجام داد.

    کلید واژگان: دیفتری, تخلیص, تقلیل مرحله ای, توکسوئید}
    Samaneh Mohammad Javad, Mojtaba Noofeli*, Ali Nazari Shirvan, Pejvak Khaki
    Background & Aim

    Diphtheria is an acute vaccine-controlled respiratory disease caused by the gram-positive bacterium Corynebacterium diphtheria. Since the preparation, purification, and detoxification of the vaccine against this disease involves many and complex steps, the present study aimed reduction of time of various stages of toxoid purification.

    Materials & Methods

    For this purpose, three factors were first optimized for the concentration of iron in the culture medium, incubation temperature and rotation speed to produce more toxins. In each case, the experiment was carried out in triplicate and Lf and Kf values were tested to evaluate toxin production. After toxin inactivation and production of the toxoid, step reductions were performed to purify the toxoid. For this, ultrafiltration, precipitation, dialysis and chromatography with Sephadex G-25 column are used. In step reduction conditions, dialysis, chromatography or both of them were removed in the first, second and third cases, respectively. The results of each method were evaluated by SDS-PAGE and the quantitative data was analyzed using Minitab 18 (p‹0.05).

    Results

    The results for optimizing the culture medium showed that highest amounts of toxin were produced at an iron concentration of 1 mg/l, a temperature of 35 °C, and a rotation speed of 200 rpm(p‹0.05). In the reduction experiments related to toxoid purification steps, the best results were obtained in a series of purified samples with ultrafiltration, precipitation and column chromatography steps.

    Conclusion

    Since time and cost are two key factors in industrial production, toxoid production for the diphtheria vaccine can be produced at a lower cost and in less time by eliminating the two-week dialysis phase.

    Keywords: Diphtheria, Purification, Step Reduction, Toxoid}
  • Andy Omega *, Faradila Ramadian, Putri Nurra Kusumawardhany Hakim
    Introduction

     Diphtheria is an infectious disease caused by exotoxin-producing Corynebacterium diphteriae and was a leading cause of death in childhood during the prevaccine era. This toxin is usually localized in the upper respiratory tract and may cause fatal airway obstruction. Many have used orotracheal intubation to secure the airway in diphtheria cases. However, the efficacy of tracheostomy under sedation while maintaining spontaneous ventilation and analgesia using trans-tracheal and superficial cervical block remains to be elucidated.

    Case Presentation

     A 6-year-old presented to the emergency room with respiratory distress and was diagnosed with diphtheria. A thick membrane in the oropharyngeal area and chest X-ray showed infiltrations indicative of pneumonia. The patient successfully underwent emergency tracheostomy under sedation using a combination of sevoflurane and dexmedetomidine to achieve prompt sedation and trans-tracheal injection and bilateral superficial cervical block as analgesia for the intra-tracheal and the incision. The patient’s condition deteriorated the next day, and the bronchoscopy showed that the carina and main bronchus were covered by a pseudomembrane, obstructing the airway below the tracheostomy. The patient eventually died two days after admission.

    Conclusions

     Dexmedetomidine has minimal impact on ventilatory function and anti-sialagogue properties, while sevoflurane has minimal effect on respiratory depression. This case presentation showed that a combination of sevoflurane and dexmedetomidine with spontaneous assisted ventilation could be helpful in tracheostomy procedures in pediatric patients with airway obstruction due to diphtheria, along with the use of trans-tracheal and superficial cervical block as the analgesia. This report also indicates that being vigilant in rapidly-progressing and fatal pediatric diphtheria cases is vital.

    Keywords: Diphtheria, Airway Obstruction, Airway Management, Tracheostomy, Dexmedetomidine}
  • Sunarno Sunarno *, Yudi Hartoyo, Novi Amalia, Sundari Nur Sofiah, Aulia Rizki, NellyPuspandariDwi Febriyana, Tati Febrianti, Ratih Dian Saraswati, Fauzul Muna, RisqaNovita, Lisa Andriani Lienggonegoro, Fitrah Ernawati

    x

    Background

    Corynebacterium diphtheriae, C. ulcerans, andC. pseudotuberculosis are known as diphtheria-causing bacteria. Although diphtheria therapy is administered based on the clinical manifestations, some cases are mild and atypical. The immediate and accurate identification of diphtheria-causing bacteria is of paramount importance to prevent the spread of the disease and provide case management as early as possible. Unfortunately, conventional methods as the gold standard are time-consuming.

    Objectives

    This study aimed to develop and implement a multiplex real-time PCR with the dtxR and tox genes as the target to identify three species of diphtheria-causing bacteria and screen their toxigenicity quickly and accurately.

    Methods

    The research sample encompassed seven reference strains, one synthetic DNA, 30 archived isolates, and 924 clinical specimens isolated from 311 diphtheria cases and 613 close contacts. The conventional methods as the gold standard and the established PCR assay were used to verify the results of multiplex real-time PCR developed in this study.

    Results

    Themultiplex real-time PCR could identify seven reference strains, one synthetic DNA, and 30 archived isolates as accurately as the conventional methods and the established PCR. Similar to established PCR, the multiplex real-time PCR identified diphtheriacausing bacteria in 120 (38.6%) out of 311 and 12 (2%) out of 613 clinical specimens from diphtheria cases and close contacts, respectively. Meanwhile, the conventional methods identified diphtheria-causing bacteria in 79 (25.4%) out of 311 and three (0.5%) out of 613 clinical specimens.

    Conclusions

    The multiplex real-time PCR developed in this study can be used to identify three species of diphtheria-causing bacteria and screen their toxigenicity quickly and accurately. However, in this study, no diphtheria-causing bacteria other than C. diphtheriae was found in the clinical samples using the PCR or conventional methods. PCR is more sensitive than the conventional methods and can be used as an additional test in diphtheria laboratories.

    Keywords: Diphtheria, Corynebacterium diphtheria, C. ulcerans, C. pseudotuberculosis, Polymerase Chain Reaction}
  • Sunarno Sunarno *, Nelly Puspandari, Kambang Sariadji, Dwi Febriyana, Tati Febrianti, Ratih Dian Saraswati, Masri Maha, Sarwo Handayani, Christina Lestari, Vivi Setiawaty, Fitriana Fitriana, Yuyun Yuniar, Noer Endah Pracoyo, Julianti Pradono, Siswanto Siswanto, Pretty Multihartina, Nancy Anggraeni, Laili Hidayati, Agus Sukandar, Hadi Safaat, Mulya Karyanti
    Background

    The World Health Organization reported Indonesia as one of the countries with the most prevalent cases of diphtheria worldwide. The microbiological aspects of diphtheria-inducing bacteria are of great significance in tracing disease transmission and case management; however, clinical aspects are critical for updating clinical features and case management in the field, which may sometimes differ from theoretical foundations.

    Objectives

    This study aimed to identify the microbiological and clinical aspects, including molecular typing and case-fatality rates, in diphtheria confirmed cases from Capital City of Indonesia, Jakarta and surrounding areas, in 2017.

    Methods

    The microbiological aspect of 40 diphtheria confirmed cases were obtained by re-identify diphtheria-inducing bacteria isolated from the samples, while the clinical aspects of the cases were obtained from the medical record and epidemiological data. Chi-squared test was used to examine the correlation between fatal cases and myocarditis and diphtheria antitoxin (DAT) administration delay. In this study, p < 0.05 was set as the significance level.

    Results

    All 40 diphtheria confirmed cases were induced by toxigenic Corynebacterium diphtheriae with two biotypes, namely intermidius (60.0%) and mitis (40.0%). There are six sequence types of bacteria with two main sequence types, ST534 (46.4%) and ST377 (35.7%). The proportion of cases that had a fever and sore throat were 72.5% and 77.5%; however, the prevalence rates of the cases with pseudomembrane and bull neck were 100% and 47%, respectively. Most cases were administered a combination of penicillin or erythromycin with other antibiotics (40%), and 22.5% of the cases only received penicillin. Myocarditis was noticed in three fatal cases and their relationship was statistically significant (p=0.000). All five fatal cases (12.5% cases) were received DAT lately or have not received it yet.

    Conclusions

    The toxigenic C. diphtheriae with two biotypes (namely mitis and intermedius) and two main sequence types (i.e., ST534 and ST377) was the causative agent of diphtheria confirmed cases from Jakarta and surrounding area in 2017. It was also concluded that those fatal cases were correlated with myocarditis complications.

    Keywords: Corynebacterium diphtheriae, Indonesia, Diphtheria, jakarta}
  • Sunarno Sunarno*, Nelly Puspandari, Dwi Febriyana, Tati Febrianti, Ratih Dian Saraswati, Novi Sulistyaningrum, Noer Endah Pracoyo
    Background

    Indonesia is one of the five countries with the highest number of diphtheria cases worldwide. Diphtheria is caused by the toxigenic strains Corynebacterium diphtheriae, C. ulcerans, and C. pseudotuberculosis. The diphtheria-causing bacteria can be identified using conventional and molecular methods, including polymerase chain reaction (PCR) assay. We used the PCR assay as additional testing, because in island countries like Indonesia, specimen transport is a serious challenge to maintaining bacterial survival.

    Objectives

    This study aimed to evaluate the PCR assay as additional testing to identify diphtheria-causing bacteria in the diphtheria laboratory.

    Methods

    In this cross-sectional study, a total of 178 pairs of the throat and nasal swabs from diphtheria suspected cases and close contacts were collected from seven provinces in Indonesia in 2016. All samples were directly identified by the conventional method and multiplex PCR assay. Statistical analysis was conducted using the 2 × 2 tables to determine the sensitivity and specificity of both methods, while the χ 2 test was used to examine the correlation between specimen examination delay and the differentiation of results. A P-value < 0.05 was considered as statistically significant.

    Results

    Out of 178 examined samples, eight samples were identified as diphtheria-positive by both the conventional method and PCR assay, while nine samples were only detected by the PCR assay. All diphtheria-causing bacteria found in the positive samples were toxigenic C. diphtheriae. The diphtheria-causing bacteria were found in 27.6% of cases and 6.0% of close contacts using the PCR assay versus 13.8% of cases and 2.7% of close contacts using the conventional method. Statistical analysis showed that the PCR assay is about twice more sensitive than the conventional method. There was a significant correlation between the differentiation of results and > 72 hours’ specimen examination delay with a P-value of 0.04 (< 0.05).

    Conclusions

    The PCR assay is more sensitive than the conventional method to identify diphtheria-causing bacteria and may be applied as additional testing to increase the positivity rate of diphtheria-confirmed cases in Indonesia as an archipelago country where geographical factors and specimen transport are real obstacles.

    Keywords: Diphtheria, Indonesia, Multiplex Polymerase Chain Reaction}
  • صابر سلطانی، ابوالفضل داودآبادی، عباس فراهانی، مهسا دسترنج، معصومه امینی، نوید مومنی فر، شیرین پورعبدی، حجت ویسی
    ایمونوتوکسین ها مولکول هایی هستند که دارای ساختار منحصر به فرد توکسین-آنتی بادی دو عملکردی بوده و با گذر از غشای سلولی و ورود به داخل سلول هدف، باعث از بین رفتن سلول می شوند. اختصاصیت ایمونوتوکسین ها برای انتخاب هدف سلولی خود به دلیل نوع آنتی بادی انتخاب شده است و آنتی بادی مورد نظر وظیفه شناسایی سلول هدف را بر عهده دارد. سرطان در حال تبدیل شدن به عامل اصلی مرگ در بیشتر کشورهای توسعه یافته است.
    جهت در اختیار داشتن یک عامل قوی در سرکوب سرطان، آن عامل باید به طور مستقیم و اختصاصی سلول سرطانی را هدف قرار دهد.
    در بیشتر موارد ولی نه همیشه ایمونوتوکسین ها به منظور کشتن سلول های سرطانی تولید می شوند که این موضوع یکی از رویکردهای جدید درمانی در عصر حاضر است. اهداف کلینیکی بر طراحی و ایجاد درمان های جدید سرطان با این رویکرد مورد مطالعه متمرکز شده است. داده های زیادی نیز در مورد عملکرد توکسین و مسیرهای داخل سلولی به دست آمده است. بنابراین توکسین ها در علوم پزشکی برای درمان بیماری های انسانی و برای بررسی عملکردهای تخصصی سلولی بسیار مفید هستند. از دیگر کاربردهای ایمونوتوکسین ها می توان به این نکته اشاره کرد که ایمونوتوکسین ها عاملی برای تنظیم سیستم ایمنی بدن و درمان بیماری های ویروسی و انگلی می باشند. در مجموع با طراحی های مبتکرانه، هوشمندانه و کارآزموده تر می توان بسیاری از بیماری های انسانی به ویژه بدخیمی هایی همچون سرطان ها را در دوره زمانی کوتاه تر و سریع تری نسبت به سایر روش های درمانی کنونی که دوره درمان طولانی دارند، درمان کرد. پژوهش کنونی بر کاربرد توکسین های باکتریایی و گیاهی و به طور اختصاصی ایمونوتوکسین سودوموناس در سلول های سرطانی تمرکز دارد.
    کلید واژگان: آنتی بادی, سرطان, دیفتری, ایمونوتوکسین, سودوموناس, توکسین}
    Saber Soltani, Abolfazl Davoodabadi, Abbas Farahani, Mahsa Dastranj, Masomeh Amini, Navid Momenifar, Shirin Poorabdi, Hojat Veisi
    Immunotoxins such as pseudomonas exotoxin are Molecules with a unique structure like toxin-antibody part. These immunotoxins are two functional which crossing the cell membrane and enters the target cell and destroy the cell. Toxin-based treatments are a widespread research field and can have broad applications in the biology and public health. Immunotoxins act selectively against cancer cells and have a good potential for detecting and targeting cancer cells. Specific immunotoxins to target immune cells due to the selection type antibody and antibodies are responsible for the identification of the target cells. Cancer is becoming a major cause of death in most developed countries. In order to have a strong factor in cancer repression, that agent must target the cancer cells directly and specifically. Often, but not always, immunotoxins are produced for disabling and killing cancer cells, that this issue is one of new therapeutic approaches in recently. Clinical aims to designing and create new cancer therapies focused with this approach, a lot of information about the toxin and intracellular pathways have been obtained. So, toxins in medicine are useful for the treatment of human disease and study of professional cellular functions. So, immunotoxins have a high potential for cancer treatment. Other applications of immunotoxins, including immune system regulation and treatment of viral diseases and parasites diseases. More research is needed to improve the immunotoxin effects and to reduce their side effects. On the whole, with design creative, clever and experienced programs, many human diseases, particularly cancers can be in a short period of time and faster than other methods of treatment that the treatment of long, to be treated. Following the design and implementation of clinical trials, the effects of immunotoxins on animal tumorigenic models were performed. In fact, in this study, we focus on the use of protein-bound toxins with bacterial and herbal sources and more specifically Pseudomonas immunotoxins which attached to antibodies to target cancer cells.
    Keywords: antibodies, cancer, diphtheria, immunotoxins, pseudomonas, toxins}
  • Yaser Mokhayeri, Shohreh Naderimagham, Rasool Mohammadi, Ebrahim Rahimi, Shadi Rahimzadeh, Alireza Badirzadeh, Seyed Saeed Hashemi, Nazari*
    Background
    Vaccination has been one of the most successful and cost-effective public health interventions in the last century and has saved millions of lives. In 1984, the Expanded Program on Immunization (EPI) was launched in Iran as one of the main components of Primary Health Care (PHC).
    Objectives
    We aimed to investigate the burden of four vaccine-preventable diseases from 1990 to 2010 in Iran.
    Methods
    GBD study 2010 includes death rates, Years of Life Lost (YLLs), Years Lived with Disability (YLDs) and Disability Adjusted Life Years (DALYs). YLLs is calculated through multiplying the number of deaths in each age group by a reference life expectancy for the same age group, while YLDs can be obtained from the prevalence of a disease multiplied by the disability weight (DW) for the same disease. The sum of these two indices yields DALYs. In the present study, we tried to produce new graphs and explain more about Iran results. We also describe the GBD study limitations.
    Results
    Regardless of gender differences, DALYs rates for measles at all ages were 86.1220 and 5.5703 per 100 000 in 1990 and 2010, respectively, indicating approximately 94% decrease in this disease. The maximum and minimum rates of deaths from whooping cough for males aged under 5 was 4.0674 and 0.2713 per 100 000 in 1990 and 2000, respectively, which shows 93% decline in whooping cough from in this period.
    Conclusion
    This study demonstrated that vaccination has had a positive impact on the control of communicable diseases. But the results of this study have some limitations similar to GBD study which may pave the way for decision makers about other public health interventions. Moreover, since measuring the impact of various diseases on health plays an important role in public health, it can be an important step toward prioritization in health.
    Keywords: Diphtheria, Iran, measles, tetanus, vaccine, whooping cough}
  • مینا پهلوانی، حسین ذوالفقاریان، مجید تبیانیان، حسین راثی
    مقدمه
    در اواسط دهه ی 1940، ریشه کن کردن بیماری دیفتری توسط ترکیب واکسن توکسوئید دیفتری (سم غیر فعال) با واکسن کزاز و سیاه سرفه (واکسن DTP یا Diphtheria، Tetanus، Pertussis)، با موفقیت در سراسر جهان انجام شده است. هدف از این مطالعه، بهینه سازی شرایط جذب توکسوئید دیفتری در ژل فسفات آلومینیوم برای بهبود میزان جذب و افزایش اثربخشی واکسن بود.
    روش ها
    در این مطالعه، پارامترهای مختلف از جمله pH اولیه، دما و pH نهایی، که در میزان جذب توکسوئید دیفتری در ژل فسفات آلومینیوم موثر هستند، در مقیاس آزمایشگاهی و داخل بدن مورد مطالعه قرار گرفتند. به این منظور، توکسوئید دیفتری خالص شده برای تهیه و ساخت واکسن مورد استفاده قرار گرفت. توکسوئید دیفتری در هیدروکسید آلومینیوم با pH مختلف جذب اعم از 0/6، 8/5، 6/5، 4/5، 2/5 و 0/5، در معرض درجه حرارت های مختلف (شامل 37، 24 و 4 درجه ی سانتی گراد) تنظیم شد و به pH نهایی 8/6، 6/6 و 4/6 رسید.
    یافته ها
    فرمولاسیون موثر در جذب، pH برابر 8/5، در دمای 4 درجه ی سانتی گراد با pH نهایی 6/6 بود.
    نتیجه گیری
    سطح آنتی بادی در حیوانات ایمن شده توسط واکسن، به طور قابل توجهی بالا رفت. به نظر می رسد که با واکسن جدید فرموله شده و با بهینه سازی شرایط، میزان توکسوئید و سطح آنتی بادی در حیوانات واکسینه شده به طور قابل توجهی افزایش یافت.
    کلید واژگان: دیفتری, واکسن, ادجوانت, جذب, pH}
    Mina Pahlevani, Hossein Zolfagharian, Majid Tebianian, Hossein Rasi
    Background
    In the mid-1940s، the diphtheria toxoid (inactivated toxin) vaccine was developed via combination with tetanus and pertussis vaccines (DTP vaccine) and successfully conducted to eradication of diphtheria disease throughout the world. Optimization of diphtheria toxoid absorption on aluminum phosphates to improve the rate of absorption and increase the efficacy of vaccine was our aim.
    Methods
    In this study، the effect of different parameters، such as initial pH، temperature and final pH، on the adsorption rate of diphtheria toxoid on aluminum phosphate gel waz studied in vitro and vivo. Purified diphtheria toxoid was used for vaccine preparation. It was adsorbed to aluminum hydroxide with different pH values (5. 0، 5. 2، 5. 4، 5. 6، 5. 8 and 6. 0) and exposed to various temperatures (4، 24 and 37°C) and adjusted to the final pH values of 6. 4، 6. 6 and 6. 8.
    Findings
    The effective formulation was the pH of 5. 8 at the temperature of 4°C with the final pH of 6. 6.
    Conclusion
    The level of antibody in the immunized animals significantly was high. It is suggested that with new formulated vaccine with the optimized conditions، can significantly make the rate of toxoid and level of antibody high in the immunized animals.
    Keywords: Diphtheria, Vaccines, Adjuvant, Absorption, pH}
  • معصوم امرایی، مهدی زین الدینی، مسعود سلیمانی، علیرضا سعیدی نیا
    مقدمه
    ایمونوتوکسین یک پروتئین هیبریدی و دارای دو بخش کاملا مجزا است که توسط رابط های مشخص و به صورت کووالان به یکدیگر متصل هستند: یک بخش ایمنی که نقش تشخیصی و اتصال ایمونوتوکسین به گیرنده های خاص را بر عهده دارد و یک بخش توکسینی یا سمی که نقش سیتوتوکسیک و مرگ سلولی را بر عهده دارد. هدف از مطالعه حاضر، تولید یک پروتئین هیبریدی با استفاده از اتصال مولکولی توکسین دیفتری (DT) به اینترلوکین 2 انسانی (IL2)، به منظور استفاده از آن در بیماران مبتلا به لنفوما می باشد.
    مواد و روش ها
    پس از سنتز اولیه توالی ژنی رمز کننده پروتئین هیبریدی مذکور (IDZ: DT-IL2)، همسانه سازی قطعه مربوطه در سیستم بیانی pET، صورت گرفت. پلاسمید pET-IDZ تولیدی، درون باکتری BL21(DE3) منتقل و سپس القاء گردید. در ادامه تخلیص پروتئین با استفاده از سیستم کروماتوگرافی تمایلی نیکل (Ni-NTA) انجام شد و در نهایت عملکرد پروتئین هیبریدی نوترکیب تولیدی بر روی رده سرطانی K-562 که دارای گیرنده سطحی برای اینترلوکین 2 است، با استفاده از روش سنجش زیستی MTT، مورد ارزیابی و مقایسه قرار گرفت.
    یافته ها
    پس از تولید پلاسمید pET-IDZ، بیان پروتئین هیبریدی نوترکیب در باکتری BL21(DE3)، با استفاده از روش های الکتروفورز و وسترن بلات، تایید گردید. تخلیص پروتئین هیبریدی، خلوص بالای 95 دزصد را با استفاده از روش دانسیتومتری، نشان داد. در ادامه سلول هایK-562 با غلظت های مختلف پروتئین هیبریدی تولیدی، تیمار شد. نتایج حاصله نشان داد که میزانIC50% (غلظتی از پروتئین هیبریدی برای از بین بردن 50 درصد سلول ها)، 10-10 × 6 مولار است.
    نتیجه گیری
    ایمونوتوکسین یا توکسین هدف گذاری شده به عنوان یکی از استراتژی های نوین درمانی بیماران سرطانی به حساب می آیند. اولین نمونه نوترکیب این پروتئین های هیبریدی (با نام اونتاک) در سال 1999 از سازمان غذا و داروی آمریکا تاییدیه دریافت کرد که در آن توکسین دیفتری به اینترلوکین 2، متصل شده بود. با توجه به اهمیت داروی مذکور، تلاش گردید این دارو در داخل کشور تولید شود. نتایج حاصل از عملکرد اولیه نمونه تولیدی، بیانگر صحت نمونه است. ولی لازم است آزمایشات تکمیلی و مقایسه آن با نمونه خارجی صورت پذیرد.
    کلید واژگان: کلون, بیان, تخلیص, ایمونوتوکسین, دیفتری, اینترلوکین}
    Background
    Immunotoxin is a fusion protein containing two distinct sections covalently bonded by specific linkers. It includes an immunological section with a diagnostic role to connect the immunotoxin to the specific receptors and a toxic section with a cytotoxic role that leads to the cell death. The aim of this study is development of a lymphoma cancer protein therapy method using a recombinant immunotoxin produced by connecting diphtheria toxin to human interleukin 2 (IL2).
    Materials And Methods
    After the synthesis of the fusion protein gene sequence (IDZ: DT-IL2)، subcloning was done in the pET expression system. The pET-IDZ plasmid was transformed to BL21 (DE3) bacteria and then was induced. The protein purification was accomplished by nickel affinity chromatography system and then the function of the produced recombinant fusion protein was evaluated on K-562 cancerous cell line by MTT biological assay.
    Results
    After production of pET-IDZ plasmid، the expression of the recombinant fusion protein in BL21 (DE3) bacteria was validated using electrophoresis and Western Blot methods. The purification yield determined above 95% using densitometry method. Afterwards، K-562 cells were treated by different concentrations of the produced fusion protein. The results showed the proper function of the produced fusion protein. Also، IC50 % amount (immunotoxin concentration to remove 50% of the cells) was determined as 6×10-6 M.
    Conclusion
    Immunotoxin or targeted toxin is a novel strategy for cancer patients. The first recombinant immunotoxin (named Ontak)، in which diphtheria toxin had been connected to interleukin 2، was approved from United States Food and Drug Administration (FDA) in 1999. Considering the importance of this drug، recombinant fusion protein was attempted to be produced in this research. Experimental data confirmed effective protein function، but complementary studies will be required to be compared with Ontak.
    Keywords: cloning, expression, purification immunotoxin, diphtheria, interleukin}
  • Mohammad Ali Arefpour Torabi, Gholam Reza Olad, Shahram Nazarian, Jafar Salimian, Samaneh Khodi, Mohammad Javad Bagheripour
    Diphtheria is a fatal disease caused by exotoxin of Corynebacterium diphtheria. This toxin consists of two chains, catalytic chain (A) and binding (B) chain. By binding chain (B), the toxin binds to its receptor on numerous body cells such as myocardial, kidney and peripheral nerve cells. After entering, catalytic chain (A) inhibits protein synthesis and finally can cause cell death. At this time, the toxoid form of diphtheria toxin is used as vaccine. The aim of this study was the immunological analysis of the mutated synthetic catalytic subunit of diphtheria toxin in laboratory animals as a vaccine candidate, in addition to polyclonal antibody production and purification against diphtheria toxin. For this purpose the Dtx recombinant protein (with two mutant: A158G and G52E) was expressed using pET28a/DtxA plasmid in E. coli Bl21DE3 host. Then, recombinant protein, as a candidate vaccine, was extracted and purified. After evaluating and confirming the protein by SDS-PAGE and western blotting, immunization carried out in laboratory animals. Finally, followed by antibody titration by ELISA, antibody purification performed as well.The mutated recombinant protein prepared from an optimized expression was extracted and purified. Then, this protein was confirmed by SDS-PAGE and western blotting. ELISA results showed a satisfactory immunization of animals by this protein. Polyclonal antibody production and purification against diphtheria toxin was performed by G protein column and confirmed by ELISA. ELISA results showed a high titer of polyclonal antibody against diphtheria toxin in animal''s serum after immunization by recombinant DTx protein.
    Keywords: Diphtheria, Mutated DTxA Chain, Diphtheria Toxin, Recombinant Vaccine, Polyclonal Antibody}
  • Ali Eslamifar, Amitis Ramezani, Mohammad Banifazl, Masoomeh Sofian, Fatemeh, Alsadat Mahdaviani, Arezoo Aghakhani, Farhad Yaghmaie, Arezoo Aghakhani
    Background And Objectives
    Tetanus and diphtheria are vaccine-preventable, infectious diseases with significant morbidity and mortality. Immunization by the diphtheria and tetanus toxoid (DT) has been applied in Iran for almost 50 years. However, there are very few data about the rate of immunity to these diseases in the adult population. the humoral immunity to tetanus and diphtheria among blood donors in Arak city, central provice of Iran were investigated.Patients and
    Methods
    A total of 530 consecutive blood donor samples were collected from Blood Transfusion Organization, Central province of Iran. All samples were tested for diphteria and tetanus IgG antibodies using enzyme-linked immunosorbent assay (ELISA).
    Results
    From 530 cases, 91.9% were male and 8.1% were female. 99.6% of cases had protective levels of diphtheria antibody. Protective levels of tetanus antibody were found in 96% of subjects. There was not any significant difference between diphtheria and tetanus antibodies levels and age and sex.
    Conclusion
    The obtained data showed that high proportion of the adult population in Arak have sufficient protection against diphtheria and tetanus. The high protective level of immunity to diphtheria and tetanus in Iran can be due to widespread use of booster vaccines in Iranian high schools and during the military services or for pregnant women in their 3rd trimester.
    Keywords: Diphtheria, Tetanus, Antibody Level, Blood Donor}
  • Mohammadreza Modarresi, Alaleh Gheissari, Maryam Sattari
    Background
    Vaccination against fatal viral and bacterial diseases is still the best protective way to lower morbidity and mortality rate in end‑stage renal disease (ESRD) patients. It has been reported that there is high incidence of low protective levels of IgG after vaccination in ESRD adult patients. The aim of this study was to evaluate the protective status of vaccination against diphtheria and tetanus in ESRD children after completing routine vaccination.
    Methods
    This cross‑sectional study was carried on 83 participants less than 18 years including 27 patients on hemodialysis or peritoneal dialysis and 56 normal populations from February 2008 until December 2008 at St. Alzahra hospital, Isfahan, Iran. To determine anti‑tetanus and anti‑diphtheria antibodies level, Tetanus IgG ELISA kit (IBL International, Germany, RE56901) and Diphtheria IgG ELISA kit (IBL International, Germany, RE56191) were used. The participants must not received immunoglobulin, blood products or immunosuppressive medication in the current 6 months.
    Results
    The mean age of case and control group were 12.5 ± 2.7 years and 11.7 ± 3.3 years, respectively, P > 0.05. According to IgG levels, 93% of hemodialysis patients and approximately 87% of peritoneal dialysischildren needed booster doses of diphtheria vaccination. The results for IgG titer against tetanus revealed that in 91% of hemodialysis patients and 83% of peritoneal dialysis children booster doses of tetanus were recommended.
    Conclusions
    Booster doses of vaccines may be required in ESRD children. Measuring serum IgG levels against vaccines to define protective levels are recommended.
    Keywords: Children, diphtheria, end‑stage renal disease, prevention, tetanus, vaccination}
  • Ali Eslamifar, Amitis Ramezani, Mohammad Banifazl, Arezoo Aghakhani
    Background And Objectives
    HIV infected patients are at risk for vaccine-preventable infections such as tetanus and diphtheria (Td). In these patients, these antibodies tend to decline faster. Due to the limited data, this study assessed the seroprevalence of tetanus and diphtheria antibodies in HIV infected patients in Tehran, Iran.
    Materials And Methods
    This case-control study was carried out in 180 HIV infected patients fromIranian HIV/AIDS Research Center in Tehran and 90 matched healthy controls. The serum sampleswere checked with ELISA for tetanus and diphtheria antibodies.
    Results
    A total of 180 HIV positive patients with mean age 36.9±9.2 years and 90 matched controls were enrolled in the study. Tetanus antibody was lower in HIV group when compared with control group. There was no significant difference in the mean serum levels of diphtheria antibody in HIV positive patients when compared with the controls. About 93.3% and 96.6% of HIV infectedpatients had protective diphtheria and tetanus antibodies respectively. Mean tetanus and diphtheriaantibodies levels were not significantly different based on the circulating CD4+ cells.
    Conclusion
    HIV positive cases, who had received primary Td vaccination before they contractedHIV infection, can be expected to be protected against diphtheria, whereas revaccination against tetanus must be considered.
    Keywords: Tetanus, Diphtheria, Human Immunodeficiency Virus}
  • سعید زارعی، محمود جدی تهرانی، امیرحسین زرنانی، حجت الله زراعتی، شیرین بنکدار، مرتضی غضنفری، فاضل شکری

    نظر به نقش واکسن سه گانه در کاهش مرگ و میر ناشی از سه بیماری مهلک دیفتری، کزاز و سیاه سرفه، واکسیناسیون کودکان ایرانی از سال 1320 با استفاده از واکسن ساخت داخل کشور در ایران شروع شد. تحقیق حاضر، مطالعه ای آینده نگر روی 337 کودک 6-4 ساله واکسینه شده در تعدادی از مراکز بهداشتی شهر تهران با واکسن سه گانه ساخت موسسه سرم سازی رازی ایران است. از والدین کودکان واکسینه شده خواسته شد که بعد از واکسن زدن کودکان، پرسشنامه عوارض واکسن را در طول یک هفته بعد از واکسیناسیون به صورت روزانه تکمیل کنند. عوارض موضعی و عمومی به ترتیب در 92.6 و 65.3 درصد کودکان واکسینه شده مشاهده گردید. درد در ناحیه تزریق، شایع ترین عارضه موضعی بود که در 86.9 درصد از کودکان مشاهده گردید. بیشترین عوارض عمومی شامل تب (48.4 درصد)، کاهش اشتها (24 درصد)، مشکلات گوارشی (5.6 درصد)، تهوع و استفراغ (8 درصد) و کهیر یا اگزما (2.7 درصد) عمدتا در روز اول یا دوم پس از واکسیناسیون مشاهده شد که طی یک هفته به تدریج کاهش یافت. با توجه به مطالعات پراکنده گذشته بر روی این واکسن در ایران به نظر می رسد که عوارض مشاهده شده در این مطالعه نسبت به مطالعات قبلی کاهش یافته است. مقایسه عوارض واکسن مورد مطالعه با مطالعات انجام شده در کشورهای دیگر که با استفاده از واکسن های استاندارد سلولی انجام شده است، موید شیوع بالای عوارض فوق الذکر در واکسن های دیگر می باشد، گرچه شدت این عوارض در کودکان ایرانی واکسینه شده در این مطالعه بیشتر به نظر می رسد. احتمالا این عوارض با روش فرمولاسیون واکسن و نیز اجزا سلولی باکتری های استفاده شده در تولید آن ارتباط داشته باشد.

    کلید واژگان: واکسن, دیفتری, کزاز, سیاه سرفه, عوارض واکسیناسیون, کودکان}
    S.Zarei, M.Akhondi, A.H.Zamani, H.Zeraati, S.Bonakdar, M.Ghazanfari, F.Shokri *
    Objective(s)

    To detcnninc the short-term reacrogenicity of diphtheria-tetanus-whole cell pertussis (DTwP) vaccine administered to preschool children in a number of health centers of Tehran in 2006.

    Methods

    In this prospective cohort study, 337 children aged 4-6 years were injected with DTwP vaccine manufactured by Razi Institute of Iran. Reactogenicity was assessed by the parents for 7 days post vaccination using diary cards. Local (pain, redness and swelling) and systemic (fever, loss of appetite, gasterointestinal symptoms, vomiting and eczema) side effects were recorded daily.

    Results

    Out of 337 children, 312 (92.6%) reported local reactions and 220 (65.3%) reported systemic reactions. No serious adverse events related to vaccination were reported. Among local reacuons, pain was the most frequent (86.9%), but 11 was mostly mild or moderate. Redness (52.8%) and swelling (41.2%) were the most frequently observed signs in the second day. The systemic reactions observed in children included fever (48.4%), loss of appetite (24%), gastrointestinal symptoms (5 6%), vomiting (8%) and eczema (2.7%). Only 3.6% of children had auxiliary fever above 39 'c. All signs were observed to have reduced or completely disappeared during a week.

    Conclusion

    Compared with previous reports in Iran, reactogenicity of DTwP of Razi Institute seems to be reduced, but it was still more frequent than the internationally approved cellular vaccine counterparts. Reactogcnicity of the cellular triple vaccine may be related to the vaccine formulation or the bacterial cell fragments used in vaccine production.

    Keywords: Vaccine, Diphtheria, Tetanus, Pertussis, Children, Reactogenicity}
نکته
  • نتایج بر اساس تاریخ انتشار مرتب شده‌اند.
  • کلیدواژه مورد نظر شما تنها در فیلد کلیدواژگان مقالات جستجو شده‌است. به منظور حذف نتایج غیر مرتبط، جستجو تنها در مقالات مجلاتی انجام شده که با مجله ماخذ هم موضوع هستند.
  • در صورتی که می‌خواهید جستجو را در همه موضوعات و با شرایط دیگر تکرار کنید به صفحه جستجوی پیشرفته مجلات مراجعه کنید.
درخواست پشتیبانی - گزارش اشکال